Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2022 - 07 - 25 entities : Novartis ag save search
Global Pharmaceutical Drug Delivery Market (2022 to 2027) - Industry Trends, Share, Size, Growth, Opportunity and Forecasts
Published: 2022-07-25 (Crawled : 20:00) - prnewswire.com
AZNCF | News | $138.24 -4.19% 800
|
Health Technology
|
| O: 3.39%
H: 0.42%
C: -1.6%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 0.96%
H: 0.47%
C: -0.08%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 0.14%
H: 0.0%
C: 0.0%
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: -0.17%
H: 0.48%
C: 0.17%
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: 1.61%
H: 0.0%
C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -0.1%
H: 0.0%
C: 0.0%
AZN | News | $68.56 0.29% 0.29% 4.7M
|
Health Technology
|
| O: 0.62%
H: 1.09%
C: 0.23%
AMGN | $269.03 2.39% 2.33% 3.4M
|
Health Technology
|
| O: 0.37%
H: 1.66%
C: 0.6%
drug global market
Global Topical Drug Delivery Market Report to 2027 - Featuring Nestle, GlaxoSmithKline and Novartis Among Others
Published: 2022-07-25 (Crawled : 18:00) - prnewswire.com
GLAXF | News | $20.2 -14.18% 510
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: 0.0%
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: 3.12%
H: 0.06%
C: 0.06%
TARO | $42.25 0.14% 0.0% 17K
|
Health Technology
|
| O: 0.08%
H: 3.37%
C: -1.86%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 0.06%
H: 0.31%
C: 0.19%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 0.35%
H: 0.0%
C: 0.0%
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: 0.76%
H: 0.19%
C: -1.06%
drug global report novartis market
Diffuse Large B-Cell Lymphoma (DLBCL) Therapeutics Market Size to Grow by USD 1.79 billion, AbbVie Inc. and Bayer AG Among Key Vendors - Technavio
Published: 2022-07-25 (Crawled : 06:00) - prnewswire.com
GLAXF | News | $20.2 -14.18% 510
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: 0.0%
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: 3.12%
H: 0.06%
C: 0.06%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 0.06%
H: 0.31%
C: 0.19%
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: 0.76%
H: 0.19%
C: -1.06%
ADCT | $4.72 -0.84% 0.0% 320K
|
Health Technology
|
| O: 0.14%
H: 0.0%
C: -2.31%
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: 0.18%
H: 0.0%
C: 0.0%
CTIC | $9.09 0.05% 11M
|
Health Technology
|
| O: -7.8%
H: 3.72%
C: 2.37%
AMGN | $269.03 2.39% 2.33% 3.4M
|
Health Technology
|
| O: 0.37%
H: 0.9%
C: 0.75%
therapeutics market
Applications for proposed first-of-a-kind multiple sclerosis biosimilar natalizumab accepted by US FDA and EMA
Published: 2022-07-25 (Crawled : 06:00) - globenewswire.com
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: 3.12%
H: 0.06%
C: 0.06%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 0.06%
H: 0.31%
C: 0.19%
fda biosimilar ema sclerosis multiple sclerosis
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
GBR | $1.42 31.48% 11.27% 990K
|
Energy Minerals
KUKE | $2.88 2.49% 7.64% 360K
|
CXM 4 | $11.34 -0.44% 4.27% 1.7M
|
Information
PVL 4 | $1.47 -0.68% 4.08% 77K
|
Energy Minerals
RNR 4 | $224.74 0.85% 3.52% 310K
|
Finance
PZG | $0.4431 0.48% 2.91% 150K
|
Non-Energy Minerals
SIX | $23.45 -0.55% 0.68% 650K
|
Consumer Services
KNSL 4 | $451.81 -0.02% 0.49% 140K
|
Finance
SENS | $0.3992 -4.04% 0.45% 2M
|
Electronic Technology
BSBR | $5.25 2.54% 0.38% 430K
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.